title: Treatment of inflammatory bowel disease patients with anti-TNF-α factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection.
authors: Department of Gastroenterology, Center for Inflammatory Bowel Disease, "Saint Panteleimon" General Hospital, Nicea, Greece, jktrian@gmail.com.
authors: John K
authors: JK
authors: Triantafillidis
authors: Aristofanis
authors: A
authors: Gikas
authors: Emmanuel
authors: E
authors: Merikas
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005756:Gastritis / Q000150:complications / Q000453:epidemiology* / Q000382:microbiology*; D016481:Helicobacter Infections; D016480:Helicobacter pylori; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha